Literature DB >> 1981561

Effects of dopamine, D-1 and D-2 dopaminergic agonists on the excitability of hippocampal CA1 pyramidal cells in guinea pig.

N Berretta1, F Berton, R Bianchi, M Capogna, W Francesconi, M Brunelli.   

Abstract

In hippocampal pyramidal cells (HPCs), Dopamine (DA) application (1 microM) produced, in 50% of recorded cells, an hyperpolarization of the resting membrane potential (r.m.p.) and an increase of the afterhyperpolarization (AHP) amplitude and duration in 79% of recorded cells. DA-induced effects on both the r.m.p. and AHP were mimicked by bath application of a D-1 selective agonist, SKF 38393 (20 microM). In addition, we have observed that a D-1 selective antagonist such as SCH 23390 (1 microM) abolished the action of both DA and SKF 38393. In contrast, the activation of D-2 receptors through LY 171555 (10 microns) produced, in 50% of cells, a depolarization of the r.m.p. and a depression of the AHP in 67% of recorded cells. These results suggest that the effects observed in hippocampal pyramidal neurons after DA application of micromolar concentration are mediated by D-1 subtype of receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981561     DOI: 10.1007/bf00232200

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  32 in total

1.  Further characteristics of hippocampal CA1 cells in vitro.

Authors:  P A Schwartzkroin
Journal:  Brain Res       Date:  1977-06-03       Impact factor: 3.252

2.  Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase.

Authors:  H Simon; M Le Moal; A Calas
Journal:  Brain Res       Date:  1979-12-07       Impact factor: 3.252

3.  Probable calcium spikes in hippocampal neurons.

Authors:  P A Schwartzkroin; M Slawsky
Journal:  Brain Res       Date:  1977-10-21       Impact factor: 3.252

4.  Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.

Authors:  D R Sibley; S E Leff; I Creese
Journal:  Life Sci       Date:  1982-08-16       Impact factor: 5.037

5.  Neuroleptics decrease calcium-activated potassium conductance in hippocampal pyramidal cells.

Authors:  T G Dinan; V Crunelli; J S Kelly
Journal:  Brain Res       Date:  1987-03-24       Impact factor: 3.252

6.  D-1 dopamine receptors in the rat brain: autoradiographic localization using [3H]SCH 23390.

Authors:  T M Dawson; D R Gehlert; H I Yamamura; A Barnett; J K Wamsley
Journal:  Eur J Pharmacol       Date:  1985-02-05       Impact factor: 4.432

7.  Micro-electrophoretic studies of neurones in the cat hippocampus.

Authors:  T J Biscoe; D W Straughan
Journal:  J Physiol       Date:  1966-03       Impact factor: 5.182

8.  The membrane potential of cat hippocampal neurons recorded in vivo displays four different reaction-mechanisms to iontophoretically applied transmitter agonists.

Authors:  P L Herrling
Journal:  Brain Res       Date:  1981-05-18       Impact factor: 3.252

9.  Anomalous inward rectification in hippocampal neurons.

Authors:  J R Hotson; D A Prince; P A Schwartzkroin
Journal:  J Neurophysiol       Date:  1979-05       Impact factor: 2.714

10.  Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells.

Authors:  H L Haas; A Konnerth
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

View more
  10 in total

1.  Dopaminergic modulation of sodium current in hippocampal neurons via cAMP-dependent phosphorylation of specific sites in the sodium channel alpha subunit.

Authors:  A R Cantrell; R D Smith; A L Goldin; T Scheuer; W A Catterall
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

2.  Neuromodulatory control of neocortical microcircuits with activity-dependent short-term synaptic depression.

Authors:  Bo Cartling
Journal:  J Biol Phys       Date:  2004-09       Impact factor: 1.365

3.  Comparison of the Role of D1- and D2-Like Receptors in the CA1 Region of the Hippocampus in the Reinstatement Induced by a Subthreshold Dose of Morphine and Forced Swim Stress in Extinguished Morphine-CPP in Rats.

Authors:  Farzaneh Nazari-Serenjeh; Laleh Rezaee; Shahram Zarrabian; Abbas Haghparast
Journal:  Neurochem Res       Date:  2018-09-08       Impact factor: 3.996

4.  A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus.

Authors:  P P Sanna; F Berton; M Cammalleri; M K Tallent; G R Siggins; F E Bloom; W Francesconi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  PACAP-38 enhances excitatory synaptic transmission in the rat hippocampal CA1 region.

Authors:  M Roberto; M Brunelli
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

6.  Low ethanol concentrations enhance GABAergic inhibitory postsynaptic potentials in hippocampal pyramidal neurons only after block of GABAB receptors.

Authors:  F J Wan; F Berton; S G Madamba; W Francesconi; G R Siggins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.

Authors:  A M Alam; M S Starr
Journal:  Exp Brain Res       Date:  1994       Impact factor: 1.972

8.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

9.  Dopamine regulates intrinsic excitability thereby gating successful induction of spike timing-dependent plasticity in CA1 of the hippocampus.

Authors:  Elke Edelmann; Volkmar Lessmann
Journal:  Front Neurosci       Date:  2013-03-06       Impact factor: 4.677

10.  Dopaminergic suppression of synaptic transmission in the lateral entorhinal cortex.

Authors:  Douglas A Caruana; C Andrew Chapman
Journal:  Neural Plast       Date:  2008       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.